Latest News  

Can Lupus Be Prevented? Research Reveals Clues to Who’s Most Likely to Transition to Classified Disease

How does a patient transition from health to active SLE? This question is the crux of the research conducted by Judith A. James, MD, PhD, and colleagues… [Read More]

15% E/M Services Reimbursement Hike a Win for Rheumatology

ACR advocacy leaders are celebrating a 15% planned increase in reimbursement for rheumatology evaluation and management services and are calling on members to thank Congress. [Read More]

Changes & Additions to RISE Measures in 2020

Using RISE? Check out the updates for 2020, including five new measures available only through the RISE registry. [Read More]

Increasing Opioid Dose May Not Help Chronic Pain

NEW YORK (Reuters Health)—In patients with chronic musculoskeletal pain, an increase in opioid dosage appears to be of no clear benefit, according to a two-year… [Read More]

A Combined Immunosuppressive Regimen for ILD MDA5-Positive Dermatomyositis

Interstitial lung disease accompanied by anti-melanoma differentiation-associated gene 5 positive dermatomyositis is often rapidly progressive and associated with poor prognosis. In this study, a combined immunosuppressive regimen of high-dose glucocorticoids, tacrolimus and intravenous cyclophosphamide proved more effective than treatment with high-dose glucocorticoids and stepwise addition of an immunosuppressant in a historical control group. [Read More]

RheumPAC Announces New Donor Benefits in 2020

Donors at each giving level will receive recognition and special benefits at the ACR’s 2020 annual meeting. [Read More]

View More Latest News »